Literature DB >> 17557966

Genetic changes of CEBPA in cancer: mutations or polymorphisms?

Carlos Resende, Gonçalo Regalo, Cecília Durães, Fátima Carneiro, José C Machado.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17557966     DOI： 10.1200/JCO.2007.10.7227

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

1.  Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk molecular features: a Cancer and Leukemia Group B Study.

Authors:  Guido Marcucci; Kati Maharry; Michael D Radmacher; Krzysztof Mrózek; Tamara Vukosavljevic; Peter Paschka; Susan P Whitman; Christian Langer; Claudia D Baldus; Chang-Gong Liu; Amy S Ruppert; Bayard L Powell; Andrew J Carroll; Michael A Caligiuri; Jonathan E Kolitz; Richard A Larson; Clara D Bloomfield
Journal:  J Clin Oncol       Date:  2008-09-22       Impact factor: 44.544

2.  Molecular study of CEBPA in familial hematological malignancies.

Authors:  R El Abed; V Bourdon; L Huiart; F Eisinger; A Khelif; M Frenay; P Gesta; L Demange; H Dreyfus; V Bonadona; C Dugast; H Zattara; L Faivre; T Noguchi; R Sauvan; Z Soua; H Sobol
Journal:  Fam Cancer       Date:  2009       Impact factor: 2.375

3.  Novel mutations in CEBPA in Korean Patients with acute myeloid leukemia with a normal karyotype.

Authors:  Sollip Kim; Dong-Hwan Dennis Kim; Jun-Ho Jang; Chul-Won Jung; Mi-Ae Jang; Chang-Seok Ki; Jong-Won Kim; Sun-Hee Kim; Hee-Jin Kim
Journal:  Ann Lab Med       Date:  2012-02-23       Impact factor: 3.464

4.  CEBPA-bZip mutations are associated with favorable prognosis in de novo AML: a report from the Children's Oncology Group.

Authors:  Katherine Tarlock; Adam J Lamble; Yi-Cheng Wang; Robert B Gerbing; Rhonda E Ries; Michael R Loken; Lisa Eidenschink Brodersen; Laura Pardo; Amanda Leonti; Jenny L Smith; Tiffany A Hylkema; William G Woods; Todd M Cooper; E Anders Kolb; Alan S Gamis; Richard Aplenc; Todd A Alonzo; Soheil Meshinchi
Journal:  Blood       Date:  2021-09-30       Impact factor: 25.476
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.